Latest Insider Transactions at Collegium Pharmaceutical, Inc (COLL)
This section provides a real-time view of insider transactions for Collegium Pharmaceutical, Inc (COLL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of COLLEGIUM PHARMACEUTICAL, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of COLLEGIUM PHARMACEUTICAL, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2023
|
Rita J. Balice Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+20.15%
|
-
|
|
May 18
2023
|
Garen G Bohlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.94%
|
-
|
|
May 18
2023
|
Gino Santini Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+12.59%
|
-
|
|
May 18
2023
|
Gwen A Melincoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.94%
|
-
|
|
May 18
2023
|
John A. Fallon Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.2%
|
-
|
|
May 18
2023
|
John Gordon Freund Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+17.94%
|
-
|
|
Mar 15
2023
|
Colleen Tupper EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31,640
-23.08%
|
$727,720
$23.77 P/Share
|
|
Mar 01
2023
|
Scott Dreyer EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,324
-8.99%
|
$346,424
$26.7 P/Share
|
|
Feb 13
2023
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
11,250
-2.74%
|
$292,500
$26.88 P/Share
|
|
Feb 13
2023
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+2.66%
|
$168,750
$15.9 P/Share
|
|
Feb 13
2023
|
Shirley R. Kuhlmann EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
21,811
-13.69%
|
$567,086
$26.88 P/Share
|
|
Feb 10
2023
|
Thomas B Smith EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,185
+50.0%
|
-
|
|
Feb 10
2023
|
Scott Dreyer EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,326
-6.48%
|
$554,476
$26.75 P/Share
|
|
Feb 10
2023
|
Scott Dreyer EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,734
+17.42%
|
-
|
|
Feb 10
2023
|
Joseph Ciaffoni President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
103,857
-10.87%
|
$2,700,282
$26.75 P/Share
|
|
Feb 10
2023
|
Joseph Ciaffoni President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
255,194
+22.87%
|
-
|
|
Feb 10
2023
|
Colleen Tupper EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,854
-3.73%
|
$282,204
$26.75 P/Share
|
|
Feb 10
2023
|
Colleen Tupper EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,610
+16.4%
|
-
|
|
Feb 10
2023
|
Shirley R. Kuhlmann EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
24,046
-6.76%
|
$625,196
$26.75 P/Share
|
|
Feb 10
2023
|
Shirley R. Kuhlmann EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
73,864
+17.85%
|
-
|
|
Jan 09
2023
|
Scott Dreyer EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,834
-5.12%
|
$481,518
$27.83 P/Share
|
|
Dec 27
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
2,204
-0.44%
|
$50,692
$23.92 P/Share
|
|
Dec 27
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
19,815
-24.17%
|
$455,745
$23.9 P/Share
|
|
Dec 27
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,815
+18.68%
|
$317,040
$16.15 P/Share
|
|
Dec 23
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
147
-0.06%
|
$3,381
$23.0 P/Share
|
|
Dec 23
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
4,989
-15.11%
|
$114,747
$23.0 P/Share
|
|
Dec 23
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,989
+13.13%
|
$79,824
$16.15 P/Share
|
|
Dec 22
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
110
-0.04%
|
$2,530
$23.0 P/Share
|
|
Dec 22
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
237
-0.84%
|
$5,451
$23.0 P/Share
|
|
Dec 22
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
237
+0.83%
|
$3,792
$16.15 P/Share
|
|
Dec 21
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
7,333
-2.84%
|
$168,659
$23.11 P/Share
|
|
Dec 21
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
46,600
-62.45%
|
$1,071,800
$23.11 P/Share
|
|
Dec 21
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
46,600
+38.44%
|
$745,600
$16.15 P/Share
|
|
Dec 20
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
9,375
-3.5%
|
$215,625
$23.07 P/Share
|
|
Dec 20
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
33,758
-54.64%
|
$776,434
$23.08 P/Share
|
|
Dec 20
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,758
+35.33%
|
$540,128
$16.15 P/Share
|
|
Dec 19
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
1,134
-0.42%
|
$26,082
$23.01 P/Share
|
|
Dec 19
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
3,606
-11.4%
|
$82,938
$23.04 P/Share
|
|
Dec 19
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,606
+10.23%
|
$57,696
$16.15 P/Share
|
|
Dec 13
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
161,687
-85.23%
|
$3,557,114
$22.16 P/Share
|
|
Dec 13
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
161,687
+26.21%
|
$2,263,618
$14.91 P/Share
|
|
Dec 12
2022
|
Michael Thomas Heffernan Director |
SELL
Open market or private sale
|
Direct |
27,920
-49.91%
|
$614,240
$22.01 P/Share
|
|
Dec 12
2022
|
Michael Thomas Heffernan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,920
+15.56%
|
$390,880
$14.91 P/Share
|
|
Dec 02
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
54,400
-16.82%
|
$1,251,200
$23.07 P/Share
|
|
Dec 01
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
76,653
-19.16%
|
$1,686,366
$22.47 P/Share
|
|
Dec 01
2022
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
76,653
+16.08%
|
$1,149,795
$15.9 P/Share
|
|
Nov 28
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
43
-0.01%
|
$946
$22.0 P/Share
|
|
Nov 28
2022
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43
+0.01%
|
$645
$15.9 P/Share
|
|
Nov 22
2022
|
Joseph Ciaffoni President and CEO |
SELL
Open market or private sale
|
Direct |
65
-0.02%
|
$1,430
$22.0 P/Share
|
|
Nov 22
2022
|
Joseph Ciaffoni President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65
+0.02%
|
$975
$15.9 P/Share
|